Legal Representation
Attorney
Margaret McHugh
USPTO Deadlines
Next Deadline
8 days remaining
Published for Opposition
Due Date
July 17, 2025
Extension Available
Until August 17, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 17, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 17, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jun 11, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 14, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| May 14, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 14, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| May 14, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| May 14, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| May 12, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| May 8, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 8, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Feb 13, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Feb 13, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Feb 13, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Feb 13, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Feb 13, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jan 27, 2025 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED |
| Jan 27, 2025 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Jan 17, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jan 17, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Jan 17, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Nov 15, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Medical and scientific research in the field of pharmaceutical development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
First Use Anywhere:
Oct 1, 2018
First Use in Commerce:
Oct 1, 2018
Additional Information
Design Mark
The mark consists of the wording "ATOSSA THERAPEUTICS" next to a drawing of a partial face.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"